Idalopirdine - Lundbeck A/S
Alternative Names: DB-109; Lu AE58054; LU-AE58054; SGS-518Latest Information Update: 05 Nov 2023
At a glance
- Originator Eli Lilly and Company
- Developer Lundbeck A/S; Otsuka Pharmaceutical
- Class Antidementias; Antipsychotics; Benzylamines; Fluorobenzenes; Indoles; Nootropics; Phenyl ethers; Small molecules
- Mechanism of Action Serotonin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Cognition disorders